Market access for a new drug relates to swift and continuous access to new medical therapies for eligible patients at an acceptable cost. Next to pricing and potential reimbursement it typically includes reviewing clinical value versus existing treatments, health technology assessment (HTA), payer and physician acceptance, regulatory approval and patient access conditions.
